Opus Genetics (IRD) Operating Expenses (2022 - 2024)
Opus Genetics (IRD) has disclosed Operating Expenses for 6 consecutive years, with $13.9 million as the latest value for Q4 2021.
- On a quarterly basis, Operating Expenses changed N/A to $13.9 million in Q4 2021 year-over-year; TTM through Sep 2022 was $13.9 million, a 341.71% increase, with the full-year FY2022 number at $21.6 million, down 7.17% from a year prior.
- Operating Expenses was $13.9 million for Q4 2021 at Opus Genetics, up from $3.1 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $13.9 million in Q4 2021 to a low of $13.9 million in Q4 2021.